NCT02012972View on ClinicalTrials.gov

Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population

CompletedOBSERVATIONAL
Enrollment

354

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Antiretroviral Therapy, Highly ActiveDiabetes Mellitus, Type 2Cardiovascular Diseases
Interventions
BEHAVIORAL

Referral for NCD care

Subjects in the NCD Risks group not already receiving care for the condition will be referred to a primary health clinic for care.

Trial Locations (1)

Unknown

Thuthukani Health Centre, Johannesburg

All Listed Sponsors
collaborator

University of Witwatersrand, South Africa

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

City of Johannesburg

UNKNOWN

lead

Boston University

OTHER

NCT02012972 - Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population | Biotech Hunter | Biotech Hunter